Fustm1.1Neas
Targeted Allele Detail
|
|
| Symbol: |
Fustm1.1Neas |
| Name: |
fused in sarcoma; targeted mutation 1.1, Neil A Shneider |
| MGI ID: |
MGI:7510130 |
| Synonyms: |
FusP517L |
| Gene: |
Fus Location: Chr7:127565276-127581204 bp, + strand Genetic Position: Chr7, 69.87 cM
|
| Alliance: |
Fustm1.1Neas page
|
|
| Germline Transmission: |
Earliest citation of germline transmission:
J:326930
|
| Parent Cell Line: |
Other (see notes) (ES Cell)
|
| Strain of Origin: |
C57BL/6N
|
|
| Allele Type: |
|
Targeted (Humanized sequence) |
| Mutation: |
|
Nucleotide substitutions
|
| |
|
Mutation details: A proline to leucine substitution at amino acid 527 (p.P517L) was introduced in exon 15. The FRT-flanked neomycin resistance cassette that was inserted 50 bp downstream of the end of the 3 UTR was removed via flp-mediated recombination. This mutation is equivalent to the human P525L allele associated with a rapidly progressive, juvenile-onset form of amyotrophic lateral sclerosis.
(J:326930)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Fus Mutation: |
57 strains or lines available
|
|
|
GFP-expressing LB10 mouse embryonic stem cells derived from a C57BL6/N mouse.
|
| Original: |
J:326930 Korobeynikov VA, et al., Antisense oligonucleotide silencing of FUS expression as a therapeutic approach in amyotrophic lateral sclerosis. Nat Med. 2022 Jan;28(1):104-116 |
| All: |
2 reference(s) |
|